Dr Emma Longland

Senior Patent Attorney

Emma entered the patent profession in 2007, working in private practice and joining HGF Limited as a Senior Patent Attorney in July 2016.  She is experienced in all aspects of patent work, including drafting and prosecution of patent applications, defending and attacking patents during EPO oppositions and appeals, and providing freedom to operate and due diligence advice.

Emma has always had a wide-ranging practice, working for clients in many different fields, although with an emphasis on the medical and biotechnology fields.  This has included cases concerning, for example, nucleic acid extraction and amplification, vaccines, humanised antibodies, anti-cancer pharmaceuticals, treatments for autism-spectrum disorders, medical devices, electronic smoking devices, and green technology, particularly carbon dioxide capture and storage.

Emma has an MA in Natural Sciences, an MSci, specialising in Biochemistry, and a PhD, all from the University of Cambridge.  Her PhD research involved investigating the transcriptome changes that occur during the development of HPV-induced cancers of the uterine cervix.

In 2012, Emma achieved the highest score among those, throughout Europe, sitting the European Qualifying Examinations Amendment (Chemistry) paper.